BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 22472152)

  • 1. Gastrointestinal stromal tumors: diagnosis and treatment.
    Acín-Gándara D; Pereira-Pérez F; Castaño-Pascual A; Durán-Poveda M; Antequera-Pérez A; Miliani-Molina C
    Cir Cir; 2012; 80(1):44-51. PubMed ID: 22472152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors (GIST): a single center experience.
    Kostka R; Gürlich R; Koldová L
    Acta Chir Belg; 2012 Jan; 112(1):33-9. PubMed ID: 22442907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
    Tirumani SH; Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH; Raut CP
    Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
    Gold JS; Dematteo RP
    Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal stromal tumour: our experience].
    Versaci A; Macrì A; Ieni A; Terranova M; Leonello G; Saladino E; Speciale G; Famulari C
    Chir Ital; 2009; 61(2):161-9. PubMed ID: 19536989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of gastrointestinal stromal tumors--a comprehensive review.
    Lai EC; Lau SH; Lau WY
    Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
    Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
    JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastrointestinal stromal tumors (GIST). Clinical characteristics, diagnosis, and therapy in five cases].
    Ludolph T; Schweitzer A; Bremer A; Schulz U; Glasbrenner B
    Med Klin (Munich); 2006 Jan; 101(1):69-74. PubMed ID: 16418817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GIST: our experience].
    Rossi MT; Fasano G; Morlino A; Scutari F
    G Chir; 2009; 30(1-2):41-5. PubMed ID: 19272232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: the biology, diagnosis and management of gastrointestinal stromal tumours.
    Iorio N; Sawaya RA; Friedenberg FK
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1376-86. PubMed ID: 24749828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes.
    Marano L; Boccardi V; Marrelli D; Roviello F
    Eur J Surg Oncol; 2015 Jul; 41(7):814-22. PubMed ID: 25956211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern treatment of gastric gastrointestinal stromal tumors.
    Roggin KK; Posner MC
    World J Gastroenterol; 2012 Dec; 18(46):6720-8. PubMed ID: 23239909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
    Koo DH; Ryu MH; Ryoo BY; Beck MY; Na YS; Shin JG; Lee SS; Kim EY; Kang YK
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):173-82. PubMed ID: 25417047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment progress of gastrointestinal stromal tumor].
    Ji X; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):292-6. PubMed ID: 23536354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
    Shen C; Chen H; Yin Y; Chen J; Zhang B; Chen Z; Chen J
    Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 156 patients with gastrointestinal stromal tumors receiving imatinib therapy].
    Zhang L; Cai M; Deng J; Wang X; Wang B; Liu N; Pan Y; Zhang R; Cui Q; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):331-4. PubMed ID: 24760639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.
    Kitamura Y; Hirota S; Nishida T
    Cancer Sci; 2003 Apr; 94(4):315-20. PubMed ID: 12824897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry.
    Call J; Walentas CD; Eickhoff JC; Scherzer N
    BMC Cancer; 2012 Mar; 12():90. PubMed ID: 22429770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
    Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
    Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era.
    Wu PC; Langerman A; Ryan CW; Hart J; Swiger S; Posner MC
    Surgery; 2003 Oct; 134(4):656-65; discussion 665-6. PubMed ID: 14605627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.